ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Association between immunologic markers and cirrhosis in individuals with chronic hepatitis B

Argirion, Ilona*; Pfeiffer, Ruth M.; Lam, Tram Kim; O'Brien, Thomas R.; Yu, Kelly; McGlynn, Katherine A.; Petrick, Jessica L.; Pinto, Ligia; Chen, Chien-Jen; Lee, Mei-Hsuan; Hildesheim, Allan; Yang, Hwai-, I; Koshiol, Jill河北医科大学; 中国科学院; NIH; 6
2021-11-15DOI: 10.1038/s41598-021-00455-8
10阅读
引用收藏
分享

摘要

Host immune response and chronic inflammation associated with chronic hepatitis B virus (HBV) infection play a key role in the pathogenesis of liver diseases such as cirrhosis and hepatocellular carcinoma (HCC). We sampled 175 HCC, 117 cirrhotic and 165 non-cirrhotic controls from a prospective cohort study of chronically HBV-infected individuals. Multivariable polytomous logistic regression and canonical discriminant analysis (CDA) were used to compare baseline plasma levels for 102 markers in individuals who developed cirrhosis vs. controls and those who developed HCC vs. cirrhosis. Leave-one-out cross validation was used to generate receiver operating characteristic curves to compare the predictive ability of marker groups. After multivariable adjustment, HGF (Q4v1OR: 3.74; p-trend = 0.0001), SLAMF1 (Q4v1OR: 4.07; p-trend = 0.0001), CSF1 (Q4v1OR: 3.00; p-trend = 0.002), uPA (Q4v1OR: 3.36; p-trend = 0.002), IL-8 (Q4v1OR: 2.83; p-trend = 0.004), and OPG (Q4v1OR: 2.44; p-trend = 0.005) were all found to be associated with cirrhosis development compared to controls; these markers predicted cirrhosis with 69% accuracy. CDA analysis identified a nine marker model capable of predicting cirrhosis development with 79% accuracy. No markers were significantly different between HCC and cirrhotic participants. In this study, we assessed immunologic markers in relation to liver disease in chronically-HBV infected individuals. While validation in required, these findings highlight the importance of immunologic processes in HBV-related cirrhosis.

学科与关键词

关键词
PLASMINOGEN-ACTIVATORLIVER-CANCERC VIRUSHEPATOCELLULAR-CARCINOMANATURAL-HISTORYKAPPA-BSERUMRISKINJURYMECHANISMS
相关
加载中…
  • Single-cell landscape of immune cells during the progression from HBV infection to HBV cirrhosis and HBV-associated hepatocellular carcinoma
    Bai, Qingquan*; Li, Runyang; He, Xiao; Hong, Xiaoting; Yan, Ying; Zhao, Zhengyang; Lin, Han; Tacke, Frank; Engelmann, Cornelius*; Hu, Tianhui*Frontiers in Immunology, 2023, 14: 1320414.
  • Serum Fibroblast Growth Factor 19 as a Biomarker in Hepatitis B Virus-Related Liver Disease
    Miao, Xin; Wu, Guicheng*; An, Xuan; Guo, Xiqing; Peng, ChuyanHepatitis Monthly, 2022, 22(1): e130652.
  • Single-cell landscape of immune cells in human livers affected by HBV-related cirrhosis
    Bai, Qingquan; Hong, Xiaoting; Lin, Han; He, Xiao; Li, Runyang; Hassan, Mohsin; Berger, Hilmar; Tacke, Frank*; Engelmann, Cornelius*; Hu, Tianhui*JHEP REPORTS, 2023, 5(11): 100883.被引 1
查看全部 →

发表信息

论文状态
公开发表
发表日期
2021-11-15
卷期
第 11 卷, 第 1 期
页码
21194
DOI
10.1038/s41598-021-00455-8
语言
ENGLISH
期刊收录
NSL
期刊等级
3区
成果收录
SCIE
资助标注
Academia Sinica in TaiwanAcademia Sinica - Taiwan; Ministry of Science and Technology in TaiwanMinistry of Science and Technology, Taiwan [101-2314-B-001005-MY3]; Intramural Research Program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and GeneticsUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics [Z99 CA999999]

作者

  • A

    Argirion, Ilona (通讯) (第一作者)

    6 · nih

  • P

    Pfeiffer, Ruth M.

查看全部 13 位作者收起作者
  • L

    Lam, Tram Kim

  • O

    O'Brien, Thomas R.

  • Y

    Yu, Kelly

  • M

    McGlynn, Katherine A.

  • P

    Petrick, Jessica L.

  • P

    Pinto, Ligia

  • C

    Chen, Chien-Jen

    acad sinica

  • L

    Lee, Mei-Hsuan

  • H

    Hildesheim, Allan

  • Y

    Yang, Hwai-, I

    acad sinica · inst med

  • K

    Koshiol, Jill

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417